Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
3.6×-1.4×
Viking Therapeutics logo
Viking TherapeuticsVKTX
5.7×-38.5×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.6×+0.7×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×
Biogen logo
BiogenBIIB
3.1×+1.6×

Other financials

Income statement

See full
Revenue-—
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.7B+54.2%
Enterprise value$3.35B+37.1%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

total current assets/total current liabilities=9.3×

Based on the most recent quarter.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s current ratio?
Denali Therapeutics Inc. (DNLI) reported current ratio of 9.3× in Q1 2026.
How has Denali Therapeutics Inc.'s current ratio changed year-over-year?
Denali Therapeutics Inc.'s current ratio decreased by 2.9% year-over-year, from 9.6× to 9.3×.
What is the long-term trend for Denali Therapeutics Inc.'s current ratio?
Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s current ratio has grown at a -15.2% compound annual growth rate (CAGR), from 20.9× to 9.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.